Select Publications
Journal articles
1999, 'Bisphosphonates: From the laboratory to the clinic and back again', Bone, 25, pp. 97 - 106, http://dx.doi.org/10.1016/S8756-3282(99)00116-7
,1999, 'Effects of bisphosphonates on the inflammatory processes of activated macrophages', Phosphorus, Sulfur and Silicon and Related Elements, 144-146, pp. 321 - 324, http://dx.doi.org/10.1080/10426509908546246
,1999, 'Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs', Molecular Pharmacology, 56, pp. 131 - 140, http://dx.doi.org/10.1124/mol.56.1.131
,1999, 'Molecular mechanisms of action of bisphosphonates', Bone, 24, pp. 73S - 79S, http://dx.doi.org/10.1016/S8756-3282(99)00070-8
,1998, 'The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway', Cancer Research, 58, pp. 5294 - 5297
,1998, 'Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure- activity relationships in J774 macrophages', Journal of Bone and Mineral Research, 13, pp. 1668 - 1678, http://dx.doi.org/10.1359/jbmr.1998.13.11.1668
,1998, 'Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs', Molecular Pharmacology, 54, pp. 631 - 638
,1998, 'Mechanisms of action of etidronate and other bisphosphonates', Reviews in Contemporary Pharmacotherapy, 9, pp. 233 - 243
,1998, 'Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras', Journal of Bone and Mineral Research, 13, pp. 581 - 589, http://dx.doi.org/10.1359/jbmr.1998.13.4.581
,1998, 'Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro', Life Sciences, 62, http://dx.doi.org/10.1016/S0024-3205(97)01178-8
,1998, 'Anti-tumour activity of bisphosphonates in human myeloma cells', Leukemia and Lymphoma, 32, pp. 129 - 138, http://dx.doi.org/10.3109/10428199809059253
,1997, 'Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry', Journal of Chromatography B: Biomedical Applications, 704, pp. 187 - 195, http://dx.doi.org/10.1016/S0378-4347(97)00490-8
,1997, 'Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(β,γ-dichloromethylene) triphosphate, by mammalian cells in vitro', Journal of Bone and Mineral Research, 12, pp. 1358 - 1367, http://dx.doi.org/10.1359/jbmr.1997.12.9.1358
,1997, 'Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake', Pharmaceutical Research, 14, pp. 625 - 630, http://dx.doi.org/10.1023/A:1012157212793
,1997, 'Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity', British Journal of Haematology, 98, pp. 665 - 672, http://dx.doi.org/10.1046/j.1365-2141.1997.2713086.x
,1997, 'Introduction to bisphosphonates and the clinical pharmacology of alendronate', British Journal of Rheumatology, 36, pp. 10 - 14
,1996, 'MOLECULAR STUDIES OF APOPTOSIS INDUCED BY ANTI-RESORPTIVE BISPHOSPHONATE DRUGS', Biochemical Society Transactions, 24, pp. 568S - 568S, http://dx.doi.org/10.1042/bst024568sc
,1996, 'Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes', Biochemical and Biophysical Research Communications, 224, pp. 863 - 869, http://dx.doi.org/10.1006/bbrc.1996.1113
,1996, 'Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism', Journal of Bone and Mineral Research, 11, pp. 1482 - 1491, http://dx.doi.org/10.1002/jbmr.5650111015
,1996, 'The anti-resorptive drug clodronate is metabolised to a non-hydrolysable ATP analogue by mammalian cells in vitro', Biochemical Society Transactions, 24, http://dx.doi.org/10.1042/bst024562s
,1995, 'Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae', Molecular Pharmacology, 47, pp. 398 - 402
,1995, 'Bisphosphonates induce apoptosis in mouse macrophage-like cells by a mechanism that does not involve changes in the level of nitric oxide or p53', Bone, 17, pp. 605 - 605, http://dx.doi.org/10.1016/8756-3282(96)87972-5
,1994, 'Linkage analysis of the whirler deafness gene on mouse chromosome 4', Genomics, 21, pp. 42 - 48, http://dx.doi.org/10.1006/geno.1994.1222
,1994, 'Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum', Biochemical Journal, 303, pp. 303 - 311, http://dx.doi.org/10.1042/bj3030303
,1994, 'Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold dictyostelium discoideum', Journal of Bone and Mineral Research, 9, pp. 1029 - 1039, http://dx.doi.org/10.1002/jbmr.5650090710
,1994, 'P69. Inhibition of growth of Dictyostelium discoideum by bisphosphonates is dependent on the bisphosphonates being taken up by pinocytosis', Bone, 15, pp. 246 - 246, http://dx.doi.org/10.1016/8756-3282(94)90802-8
,1994, 'P70. Inhibition by bisphosphonates of mammalian aminoacyl-tRNA synthetase enzymes', Bone, 15, pp. 246 - 246, http://dx.doi.org/10.1016/8756-3282(94)90803-6
,1994, 'P71. The effects of bisphosphonates and their phosphinic acid analogues on bone resorption and on growth of Dictyostelium amoebae', Bone, 15, pp. 247 - 247, http://dx.doi.org/10.1016/8756-3282(94)90804-4
,1992, 'Metabolism of halogenated bisphosphonates by the cellular slime mould dictyostelium discoideum', Biochemical and Biophysical Research Communications, 189, pp. 414 - 423, http://dx.doi.org/10.1016/0006-291X(92)91574-A
,1992, 'Inhibition by bisphosphonates of growth of a wild type and resistant strain of the slime mould dictyostelium discoideum', Bone and Mineral, 17, pp. 187 - 187, http://dx.doi.org/10.1016/0169-6009(92)92086-6
,1992, 'Inhibition by bisphosphonates of growth of a wild type and resistant strain of the slime mould dictyostelium discoideum', Bone and Mineral, 17, pp. S16 - S16, http://dx.doi.org/10.1016/0169-6009(92)92277-w
,1992, 'Metabolism of bisphosphonates by the slime mould dictyostelium discoideum', Bone and Mineral, 17, pp. S16 - S16, http://dx.doi.org/10.1016/0169-6009(92)92275-u
,1992, 'Metabolism of bisphosphonates by the slime mould dictyostelium discoideum', Bone and Mineral, 17, pp. 187 - 187, http://dx.doi.org/10.1016/0169-6009(92)92084-4
,1992, 'P2. Growth inhibitory effects of bisphosphonates on the slime mould dictyostelinm discoideum', Bone, 13, pp. 275 - 276, http://dx.doi.org/10.1016/8756-3282(92)90221-h
,1991, 'Application of phosphonate and thiophosphate analogues of nucleotides to studies of some enzyme reactions', Heteroatom Chemistry, 2, pp. 163 - 170, http://dx.doi.org/10.1002/hc.520020118
,1990, 'A deductive enquiry system for a palaeontological database of museum material', Palaeontology, 33, pp. 613 - 622
,1985, 'Non-marine pelecypods from the Riversdale Group (Upper Carboniferous), Nova Scotia.', 9e congres international de stratigraphie et de geologie du Carbonifere, Washington et Champaign-Urbana, 1979. Compte rendu. Vol. 5, pp. 261 - 270
,Conference Papers
2019, 'Intravital imaging of osteoclasts in vivo reveals novel osteoclast fate which may underlie the therapeutic response to Denosumab withdrawal', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY, FL, Orlando, pp. 44 - 45, presented at Annual Meeting of the American-Society-for-Bone-and Mineral Research, FL, Orlando, 20 September 2019 - 23 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508356600130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Intravital 2-photon imaging reveals tumour-associated macrophages as the cellular targets underlying the anti-tumour activity of bisphosphonates in vivo.', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, TX, Houston, pp. S14 - S14, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TX, Houston, 12 September 2014 - 15 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000356598700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Osteoclasts on bone and dentin in vitro: Mechanism of degradation and comparison of resorption behaviour', in BONE, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S9 - S9, presented at International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor, AUSTRIA, Vienna, 29 November 2012 - 01 December 2012, http://dx.doi.org/10.1016/j.bone.2012.08.023
,2011, 'Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs', in Phosphorus, Sulfur and Silicon and the Related Elements, pp. 970 - 971, http://dx.doi.org/10.1080/10426507.2010.526674
,2011, 'Abstract LB-159: Bisphosphonates are internalised by myeloid derived suppressor cells (MDSCs) in vivo in a mouse model of breast cancer', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1538-7445.am2011-lb-159
,2010, 'Activation of γΔ T cells by bisphosphonates', in Advances in Experimental Medicine and Biology, pp. 11 - 20, http://dx.doi.org/10.1007/978-1-4419-1050-9_2
,2007, 'Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy', in Annals of the New York Academy of Sciences, pp. 209 - 257, http://dx.doi.org/10.1196/annals.1402.089
,2006, 'Alkylamines and bisphosphonates: A common mechanism for activation of γδ T-cells', in Haematologica Reports, pp. 1 - 3
,2006, 'New insights into the molecular actions of nitrogen-containing bisphosphonates', in Haematologica Reports, pp. 24 - 25
,2006, 'Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference', in Clinical Cancer Research, http://dx.doi.org/10.1158/1078-0432.CCR-06-1213
,2005, 'Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase', in Journal of Organometallic Chemistry, pp. 2679 - 2687, http://dx.doi.org/10.1016/j.jorganchem.2005.03.005
,2000, 'Bisphosphonates: Mechanisms of action in multiple myeloma', in Acta Oncologica, pp. 829 - 835, http://dx.doi.org/10.1080/028418600750063587
,2000, 'Cellular and molecular mechanisms of action of bisphosphonates', in Cancer, pp. 2961 - 2978, http://dx.doi.org/10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l
,